|
DDX10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.757600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.144600E-01 |
| Normal-vs-Stage2 |
8.857200E-01 |
| Normal-vs-Stage3 |
1.894560E-01 |
| Normal-vs-Stage4 |
9.752200E-01 |
| Stage1-vs-Stage2 |
9.823400E-01 |
| Stage1-vs-Stage3 |
1.632620E-01 |
| Stage1-vs-Stage4 |
9.385200E-01 |
| Stage2-vs-Stage3 |
2.932400E-01 |
| Stage2-vs-Stage4 |
9.374400E-01 |
| Stage3-vs-Stage4 |
3.998200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.604400E-01 |
| Normal-vs-AfricanAmerican |
2.041400E-01 |
| Normal-vs-Asian |
7.659600E-01 |
| Caucasian-vs-AfricanAmerican |
6.996100E-02 |
| Caucasian-vs-Asian |
8.193400E-01 |
| AfricanAmerican-vs-Asian |
3.807000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.491000E-01 |
| Normal-vs-Female |
7.292000E-01 |
| Male-vs-Female |
5.523200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.272800E-01 |
| Normal-vs-Extreme_Weight |
5.250200E-01 |
| Normal-vs-Obese |
6.751600E-01 |
| Normal-vs-Extreme_Obese |
4.159000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.845800E-01 |
| Normal_Weight-vs-Obese |
4.959400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.562220E-01 |
| Extreme_Weight-vs-Obese |
8.415800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.057400E-01 |
| Obese-vs-Extreme_Obese |
3.392200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.439420E-01 |
| Normal-vs-Age(41-60Yrs) |
6.499600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.749400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.200600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.934370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.907500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.747400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.270790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.287400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.455800E-01 |
| Normal-VS-Type2 PRCC |
8.289800E-01 |
| Normal-VS-KIRP CIMP |
2.770400E-01 |
| Normal-VS-Unclassified PRCC |
9.489400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.728200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.261800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.584800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.288400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.254000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.750600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.431600E-01 |
| Normal-vs-N1 |
9.469400E-01 |
| Normal-vs-N2 |
8.927600E-02 |
| N0-vs-N1 |
9.244200E-01 |
| N0-vs-N2 |
3.030400E-01 |
| N1-vs-N2 |
2.214600E-01 |
|
|
